Neurostimulation Devices Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

Neurostimulation Devices Market – Report Overview

Pacific Business Consulting’s “Neurostimulation Devices Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Neurostimulation Devices market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

The Neurostimulation Devices market, valued at over US$ 5.6 Billion in 2022, is poised for significant growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 8.0% from 2023 to 2030, potentially reaching beyond US$ 12.0 Billion by 2030.

Neurological disorders, including stroke, brain and nervous system cancers, traumatic brain injury, spinal cord injury, Alzheimer’s disease, and other dementias, Parkinson’s disease, epilepsy, and migraine, are the primary cause of disability. The absolute number of individuals affected by or living with disabilities due to neurological disorders has been on the rise globally over the past 25 years, according to the Global Burden of Disease Study 2019. These disorders are increasingly acknowledged as among the most prevalent conditions, imposing a significant burden on patients, their families, and society. Data from the Epilepsy Centre in 2020 indicates that approximately 50 million people worldwide live with epilepsy, and around 2.4 million new cases are diagnosed annually. Furthermore, the majority of epilepsy cases are idiopathic, with no identifiable cause. Parkinson’s disease (PD) affects 1-2 per 1000 of the population at any given time, according to the Global Burden of Disease Study 2019, with its prevalence increasing with age, affecting 1% of the population above 60 years. The World Health Organization (2022) reports that around 50 million people globally have dementia, with nearly 10 million new cases every year, and 60-70% of these cases are attributed to Alzheimer’s. Urgent measures are required to alleviate this burden. The rising number of neurological cases worldwide is expected to drive the demand for neurostimulation devices in the market.

The demand for neurostimulation devices is primarily fueled by the increasing incidence of chronic neurological diseases such as migraine and epilepsy, a growing demand for these devices as add-on therapy, the prevalence of lifestyle diseases such as depression and chronic pain, the adoption of technologically advanced products, and a rising geriatric population, among other factors, during the forecast period. Additionally, companies are intensifying their research and development efforts to create products with enhanced efficacy and user-friendliness. High product efficacy in treating neurological conditions, coupled with limited treatment options, is anticipated to propel market growth in the forecast period. The surge in depression cases is also likely to contribute to market development, as neurostimulation devices offer convenient treatment by activating or inhibiting electrical brain signals.

Key players are developing neurostimulation devices that can be prescribed by health professionals for remote use. Portable neurostimulation devices for conditions like Parkinson’s and back pain have been introduced to achieve faster patient outcomes. Increasing research and development efforts in neurostimulation to explore new applications and treat disorders such as autism, stroke, sleep disorders, obesity, and others are expected to broaden the scope of neurostimulation. There is a rising demand for technologies that provide better outcomes, optimized inter-device communication, monitoring neurological episode onset, and improved user interfaces. The increasing population of the elderly, with a higher risk of neurological disorders like epilepsy, essential tremors, Parkinson’s disease, and depression-related disorders, is predicted to boost the demand for neurostimulation.

Key players in the Neurostimulation Devices segment, including Aleva Neurotherapeutic, ElectroCore Inc., EndoStim Inc., Nevro Corporation, Medtronic PLC, Cyberonics, Boston Scientific Corporation, and Abbott Laboratories, are expected to play a crucial role in shaping the future landscape of Neurostimulation Devices technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Neurostimulation Devices market. It also delves into the analysis of present and prospective market competition within the global Neurostimulation Devices market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Neurostimulation Devices market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Neurostimulation Devices market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.

Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: Neurostimulation Devices
   • Global Market Outlook: Neurostimulation Devices
2. Competitive Intelligence Analysis: Neurostimulation Devices
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Neurostimulation Devices
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Neurostimulation Devices
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Neurostimulation Devices: Ten Major Market (10MM) – Market Analysis, By Product
   • Spinal Cord Stimulators
   • Sacral Nerve Stimulators
   • Deep Brain Stimulators
   • Vagus Nerve Stimulators
   • Others
9. Neurostimulation Devices: Ten Major Market (10MM) – Market Analysis, By Application
   • Pain Management
   • Parkinson’s Disease
   • Epilepsy
   • Bowel and Bladder Control
   • Others
10. Neurostimulation Devices: Ten Major Market (10MM) – Market Analysis, By End User
    • Hospitals & Clinics
    • Ambulatory Surgical Centres
    • Others
11. Neurostimulation Devices: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

12. S. Neurostimulation Devices – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

13. K. Neurostimulation Devices – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

14. Germany Neurostimulation Devices – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

15. France Neurostimulation Devices – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

16. Italy Neurostimulation Devices – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

17. Spain Neurostimulation Devices – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

18. Japan Neurostimulation Devices – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

19. China Neurostimulation Devices – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

20. Australia Neurostimulation Devices – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

21. India Neurostimulation Devices – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Application
      • By End User

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer